PROVIDER PROFILE · NPI 1902115553

Kunal MehtaMD

PRACTICEMETROPOLITAN DIAGNOSTIC IMAGING PCSee all providers at this practice →

EndocrinologyGarden City, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,617

Unique beneficiaries

—

Total services

6,026

Distinct HCPCS

Medicare payment

$245K

Peer benchmark

Total Medicare services vs. 627 Endocrinology providers in NY — top quintile (cohort median 837).

PRESCRIBING · PART D · 2024

Total Rx claims

6,325

Beneficiaries

—

Total drug cost

$2.6M

Distinct drugs

Brand share

49.3%

Top prescribed drugs

Levothyroxine Sodium732 claims

Metformin Hcl441 claims

Metformin Hcl405 claims

Semaglutide391 claims

Levothyroxine Sodium306 claims

QUALITY · MIPS · 2024

Final MIPS score

90.8

Quality

91.8

Cost

75.2

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.66%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Kunal Mehta's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Melville, NY	38	156
Christos Paras Endocrinology · Bridgeport, CT	31	74
NYU LANGONE HOSPITALS	14	35

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history